Clinical Trials Logo

Filter by:
NCT ID: NCT05601973 Recruiting - Clinical trials for Non Small Cell Lung Cancer

AMAZE-lung: Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI

AMAZE-lung
Start date: March 27, 2023
Phase: Phase 2
Study type: Interventional

AMAZE-lung is a multicenter single-arm phase II trial. The protocol treatment consists of amivantamab, lazertinib and bevacizumab (Zirabev®), given in a three-weekly regimen. The primary objective of the trial is to assess the efficacy of amivantamab and bevacizumab added to continued treatment with the third-generation EGFR-TKI lazertinib, in patients with EGFR-mutant advanced NSCLC, who have been previously treated with a third-generation EGFR-TKI in order to provide data on treatment effect and sample size required for a future phase III trial. In addition, the safety of the treatment combination will be evaluated.

NCT ID: NCT05601453 Recruiting - Clinical trials for Aortic Valve Stenosis

The ReTAVI Prospective Observational Registry

Start date: September 5, 2023
Phase:
Study type: Observational [Patient Registry]

Patients with severe aortic stenosis (sAS) treated with transcatheter aortic valve implantation (TAVI) (increasingly younger & lower risk pts) are experiencing SVD of the index THV and thus developing an indication for a redo-TAVI procedure. The evidence on redo-TAVI (where a transcatheter heart valve [THV] is implanted into another THV) is limited, with initial data showing acceptable safety as well efficacy in highly selected and limited populations. Aim is to evaluate short- and long-term data on patients undergoing transcatheter redo-TAVI procedures with THVs for failure of a previously implanted THV and to determine VARC-3 defined efficacy and safety at 30 days and functional outcome at 1 year.

NCT ID: NCT05601375 Recruiting - Clinical trials for Fetal Growth Restriction

Speckle Tracking Echocardiography in Infants, Prenatally and Postnatally

STIPP
Start date: September 12, 2022
Phase:
Study type: Observational [Patient Registry]

Comparison of prenatal and postnatal cardiac function assessed by echocardiography using pulsed wave Doppler, Tissue Doppler and speckle tracking (strain and strain rate) between foetuses/neonates with a structural heart disease, with an fetal growth restriction (FGR) and healthy fetuses/neonates.

NCT ID: NCT05600140 Recruiting - Vision Disorders Clinical Trials

Viewing Strategy Training in Children With (Cerebral) Visual Impairment

Start date: March 6, 2024
Phase: N/A
Study type: Interventional

Viewing strategies are strategies used to process visual Information. Many children with visual impairment seem to lack systematic viewing strategies. However, it is unknown how viewing strategies differ between children with normal vision and children with (cerebral) visual impairment. In addition, viewing strategy training is often adopted in clinical practice, but till date there is no scientific evidence about effectiveness of this approach. The current project has two goals: (1) to measure viewing strategies used by children with normal vision, children with ocular visual impairment and children with CVI, and (2) to evaluate whether training viewing strategies results in more efficiënt visual Information processing.

NCT ID: NCT05600127 Recruiting - Clinical trials for Urothelial Carcinoma

Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer

CHASIT
Start date: December 1, 2022
Phase: Phase 2
Study type: Interventional

Patients with locally advanced or clinically node positive urothelial carcinoma treated with chemotherapy, will receive 3 cycles of avelumab, followed by radical surgery.

NCT ID: NCT05599191 Recruiting - Clinical trials for Refractory Chronic Cough

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

CALM-1
Start date: October 25, 2022
Phase: Phase 3
Study type: Interventional

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

NCT ID: NCT05599139 Recruiting - Clinical trials for Differentiated Thyroid Cancer

Iodine Uptake After a Low Iodine Diet

IULID
Start date: February 22, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the difference in thyroid uptake of a low dose radioactive iodine (10 MBq 123-I or 37 MBq 123-I) in athyreotic patients with differentiated thyroid carcinoma before and after a low iodine diet (LID) of 7 days. The main question it aims to answer is: • What is the difference in iodine uptake before and after a LID of 7 days? Uptake of a low dose of 123-iodine will be measured in participants before and after a low iodine diet of 7 days. Researchers will compare the uptake (%) before and after the LID.

NCT ID: NCT05597475 Recruiting - Obesity Clinical Trials

GLP1R-imaging in Post-RYGB Hypoglycemia

Start date: November 1, 2016
Phase: N/A
Study type: Interventional

In order to evaluate the difference in beta cell mass in patients with and without hyperinsulinemic hypoglycemia after Roux en Y gastric bypass (RYGB) investigators aim to compare quantitative PET imaging of the pancreas between these patient groups. These highly relevant data will provide investigators with more information on the possible role of beta cell mass in the mechanisms of hyperinsulinemic hypoglycemia bariatric surgery.

NCT ID: NCT05597202 Recruiting - Type 2 Diabetes Clinical Trials

Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes

DOTAFLAME
Start date: January 1, 2023
Phase: Phase 4
Study type: Interventional

To study the effect of type 2 diabetes (T2D) on vascular wall inflammation and hematopoietic stem cell composition in vivo, and whether these changes can be reversed with glucagon like peptide 1 receptor (GLP1R)-agonism.

NCT ID: NCT05596396 Recruiting - Well-being Clinical Trials

The Caring Universities Project: LifeHack

Start date: November 2, 2021
Phase: N/A
Study type: Interventional

Within the Caring Universities project (study protocol VCWE- 2021-175 accepted by the VCWE), the investigators have developed a guided e-health programme (LifeHack) designed to improve positive mental health in university students. With the current study, the investigators aim to examine the feasibility and acceptability of LifeHack - with and without a fixed structure - to improve students' positive mental health and well-being. The secondary goals are to gain insight into pre-test to post-test differences regarding general well-being, symptoms of depression, anxiety and quality of life.